ResMed Inc.

ResMed Inc. RSMDF Stock

$22.48   0.000000%
Add to favorites
Market Cap
$32.43B
LOW - HIGH [24H]
$22.48 - $22.48
VOLUME [24H]
$100.00
P/E Ratio
21.61
Earnings per share
$1.04
ISIN
AU000000RMD6
Price   Prediction

ResMed Inc. Price Chart

Sorry, that's all we've gotfor now...

ResMed Inc. RSMDF Financial and Trading Overview

ResMed Inc. stock price 22.48 USD
Previous Close 22.48 USD
Open 22.48 USD
Bid 20.38 USD x 10000
Ask 25.34 USD x 10000
Day's Range 22.48 - 22.48 USD
52 Week Range 11.85 - 28.25 USD
Volume 100 USD
Avg. Volume 19 USD
Market Cap 32.43B USD
Beta (5Y Monthly) 0.748
PE Ratio (TTM) 21.615385
EPS (TTM) 1.04 USD
Forward Dividend & Yield 0.26 (1.16%)
Ex-Dividend Date August 19, 2026
1y Target Est N/A

RSMDF Valuation Measures

Enterprise Value 12.33B USD
Trailing P/E 21.615385
Forward P/E 54.82927
PEG Ratio (5 yr expected) 1.3
Price/Sales (ttm) 5.735959
Price/Book (mrq) 1.9695112
Enterprise Value/Revenue 2.181
Enterprise Value/EBITDA 5.882

Trading Information

ResMed Inc. Stock Price History

Beta (5Y Monthly) 0.748
52-Week Change 35.17%
S&P500 52-Week Change 18.35%
52 Week High 28.25 USD
52 Week Low 11.85 USD
50-Day Moving Average 17.55 USD
200-Day Moving Average 22.52 USD

RSMDF Share Statistics

Avg. Volume (3 month) 19 USD
Avg. Daily Volume (10-Days) 10 USD
Shares Outstanding 1.44B
Float 573.47M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 8.83%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 2.4
Trailing Annual Dividend Yield 10.67%
5 Year Average Dividend Yield N/A
Payout Ratio 0.2301
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2026
Most Recent Quarter (mrq) June 30, 2026
Next Fiscal Year End June 30, 2027

Profitability

Profit Margin 26.94%
Operating Margin (ttm) 30.85%
Gross Margin 61.61%
EBITDA Margin 37.07%

Management Effectiveness

Return on Assets (ttm) 14.00%
Return on Equity (ttm) 24.26%

Income Statement

Revenue (ttm) 5.65B USD
Revenue Per Share (ttm) 9.71 USD
Quarterly Revenue Growth (yoy) 8.59%
Gross Profit (ttm) 3.48B USD
EBITDA 2.1B USD
Net Income Avi to Common (ttm) 1.52B USD
Diluted EPS (ttm) 1.04
Quarterly Earnings Growth (yoy) 1.00%

Balance Sheet

Total Cash (mrq) 1.47B USD
Total Cash Per Share (mrq) 2.55 USD
Total Debt (mrq) 825.92M USD
Total Debt/Equity (mrq) 12.54 USD
Current Ratio (mrq) 3.1
Book Value Per Share (mrq) 11.414

Cash Flow Statement

Operating Cash Flow (ttm) 1.81B USD
Levered Free Cash Flow (ttm) 939.25M USD

Profile of ResMed Inc.

Country United States
State CA
City San Diego
Address 9001 Spectrum Center Boulevard
ZIP 92123
Phone 858-836-5000
Website https://www.resmed.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 11370

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Q&A For ResMed Inc. Stock

What is a current RSMDF stock price?

ResMed Inc. RSMDF stock price today per share is 22.48 USD.

How to purchase ResMed Inc. stock?

You can buy RSMDF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ResMed Inc.?

The stock symbol or ticker of ResMed Inc. is RSMDF.

Which industry does the ResMed Inc. company belong to?

The ResMed Inc. industry is Medical Instruments & Supplies.

How many shares does ResMed Inc. have in circulation?

The max supply of ResMed Inc. shares is 1.44B.

What is ResMed Inc. Price to Earnings Ratio (PE Ratio)?

ResMed Inc. PE Ratio is 21.61538500 now.

What was ResMed Inc. earnings per share over the trailing 12 months (TTM)?

ResMed Inc. EPS is 1.04 USD over the trailing 12 months.

Which sector does the ResMed Inc. company belong to?

The ResMed Inc. sector is Healthcare.

$2.66T
Total marketcap
$131.46B
Total volume
BTC 59.65%     ETH 11.22%
Dominance
Select currency